The bacterial infection, invasive meningococcal disease (IMD), is caused by a gram-negative coccus, Neisseria meningitidis, which includes spectrum of infections including meningitis, bacteremia, and bacteremia pneumonia. However, this disease is rare but is associated with a high fatality of up to 50% if left untreated and often results in serious complications. It creates infection of the lining of the brain and spinal cord and is frequently transmitted through direct contact with droplets of respiratory or throat secretions from patients or asymptomatic carriers.
MARKET DYNAMICS
Increasing adoption in several countries across the globe in their national immunization programs. Additionally, surge in meningococcal outbreaks has led to upsurge in demand for meningococcal vaccines, will facilitate the growth of the market. However, stringent government regulations for the approval of new vaccines and recall of several products due to contamination are expected to prevent the market growth.
MARKET SCOPE
The "Meningococcal vaccine Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of meningococcal vaccine market with detailed market segmentation by type and brand. The meningococcal vaccine market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in meningococcal vaccine market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The meningococcal vaccine market is segmented on the basis of type and brand. Based on type, the market is segmented as bivalent, quadrivalent, and others. On the basis brand, the market is categorized as menactra, menveo, bexsero, trumenba, nimenrix, and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the meningococcal vaccine market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The meningococcal vaccine market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting meningococcal vaccine market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the meningococcal vaccine market in these regions.
MARKET PLAYERS
The report covers key developments in the meningococcal vaccine market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from meningococcal vaccine market are anticipated to have lucrative growth opportunities in the future with the rising demand for meningococcal vaccine in the global market. Below mentioned is the list of few companies engaged in the meningococcal vaccine market.
The report also includes the profiles of key players in meningococcal vaccine market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- PFIZER INC
- NOVARTIS AG
- SANOFI
- SERUM INSTITUTE OF INDIA LTD.
- GLAXOSMITHKLINE PLC
- MERCK AND CO., INC.
- HUALAN BIOLOGICAL ENGINEERING INC.
- INCEPTA PHARMACEUTICALS LTD
- WALVAX BIOTECHNOLOGY CO., LTD.
- BIO-MANGUINHOS
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.